A retrospective study of bisphosphonates and denosumab in children with Osteogenesis imperfecta
Latest Information Update: 03 Jan 2017
Price :
$35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Osteogenesis imperfecta
- Focus Therapeutic Use
- 03 Jan 2017 New trial record